Research output per year
Research output per year
Personal profile
Headline
ASSOCIATE PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
Fingerprint
Dive into the research topics where Ronald Tamler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Internet-Based Health Care Communication Among Cancer Survivors, 2011-2018 National Health Interview Survey
Liu, B., Yabroff, K. R., Zheng, Z., Tamler, R. & Han, X., 2021, In: Preventing chronic disease. 18, p. 1-13 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
EMPA-TROPISM (ATRU-4) Investigators, 26 Jan 2021, In: Journal of the American College of Cardiology. 77, 3, p. 243-255 13 p.Research output: Contribution to journal › Article › peer-review
Open Access165 Scopus citations -
Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass
Kima, S. M., Kima, S. M., Taneja, C., Taneja, C., Perez-Pena, H., Ryu, V., Ryu, V., Gumerova, A., Gumerova, A., Li, W., Ahmad, N., Ahmad, N., Zhu, L. L., Zhu, L. L., Liu, P., Liu, P., Mathew, M., Mathew, M., Korkmaz, F., Korkmaz, F., & 34 others, 23 Jun 2020, In: Proceedings of the National Academy of Sciences of the United States of America. 117, 25, p. 14386-14394 9 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?
Santos-Gallego, C. G., Garcia-Ropero, A., Mancini, D., Pinney, S. P., Contreras, J. P., Fergus, I., Abascal, V., Moreno, P., Atallah-Lajam, F., Tamler, R., Lala, A., Sanz, J., Fuster, V. & Badimon, J. J., 15 Feb 2019, In: Cardiovascular Drugs and Therapy. 33, 1, p. 87-95 9 p.Research output: Contribution to journal › Article › peer-review
42 Scopus citations -
Comparison of efficacy and safety of glargine and detemir insulin in the management of inpatient hyperglycemia and diabetes
Galindo, R. J., Davis, G. M., Fayfman, M., Reyes-Umpierrez, D., Alfa, D., Peng, L., Tamler, R., Pasquel, F. J. & Umpierrez, G. E., 1 Sep 2017, In: Endocrine Practice. 23, 9, p. 1059-1066 8 p.Research output: Contribution to journal › Article › peer-review
16 Scopus citations
Press/Media
-
9 Things That Can Happen To Your Body After You Start Taking Testosterone
12/02/23
1 item of Media coverage
Press/Media
-
Smart Meter: Sixty-Three Percent of Adults with Type 2 Diabetes Can't Send their Glucose Test Results to their Provider
16/12/22
1 item of Media coverage
Press/Media
-
Sixty-Three Percent of Adults with Type 2 Diabetes Can't Send their Glucose Test Results to their Provider
5/12/22
58 items of Media coverage
Press/Media
-
Sixty-Three Percent of Adults with Type 2 Diabetes Can’t Send their Glucose Test Results to their Provider
5/12/22
1 item of Media coverage
Press/Media
-
Forty-Seven Percent Of Persons With Type 2 Diabetes Say A Remote Patient Monitoring (RPM) Program Would Help Them Better Manage Their Health'
16/11/22
111 items of Media coverage
Press/Media